Patents Assigned to Minerva Biotechnologies Corporation
  • Method of screening for agents for differentiating stem cells
    Patent number: 11931347
    Abstract: The present application discloses a method for identifying an agent for the treatment or prevention of cancer or metastatic cancer comprising the steps of contacting stem cell with a potential agent, and identifying an agent that induces differentiation, or inhibits stem cell pluripotency or growth of the stem cell, wherein such agent is determined to be an anti-cancer agent.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: March 19, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Scott Moe
  • Method for maintaining pluripotency in cells
    Patent number: 11898160
    Abstract: The present application describes a method for inducing or maintaining pluripotency in a cell by contacting the cell with a biological or chemical species that increases MUC1* activity.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: February 13, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia C. Bamdad, Shawn P. Fessler
  • Humanized anti-MUC1* antibodies
    Patent number: 11897967
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: February 13, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Humanized anti-MUC1* antibodies
    Patent number: 11746159
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: September 5, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Method of treating an NME7 expressing cancer with a peptide
    Patent number: 11702483
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: July 18, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Media for stem cell proliferation and induction
    Patent number: 11591565
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: February 28, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • MUC1* antibodies
    Patent number: 11560435
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: January 24, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20220259324
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: August 3, 2021
    Publication date: August 18, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • NME INHIBITORS AND METHODS OF USING NME INHIBITORS
    Publication number: 20220218846
    Abstract: The present application discloses inhibitors of NME family of proteins.
    Type: Application
    Filed: December 10, 2021
    Publication date: July 14, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia C. BAMDAD, Benoit SMAGGHE
  • METHODS FOR TREATMENT OF CANCER
    Publication number: 20220202786
    Abstract: A method for treating or preventing cancer in a subject comprising administering a treatment effective amount of a chemotype 4 compound.
    Type: Application
    Filed: November 17, 2021
    Publication date: June 30, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventor: Cynthia C. BAMDAD
  • NME INHIBITORS AND METHODS OF USING NME INHIBITORS
    Publication number: 20220089779
    Abstract: The present application discloses inhibitors of NME family of proteins.
    Type: Application
    Filed: May 3, 2021
    Publication date: March 24, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia BAMDAD, Benoit Smagghe
  • Methods for treatment of cancer
    Patent number: 11202775
    Abstract: A method for treating or preventing cancer in a subject comprising administering a treatment effective amount of a chemotype 4 compound.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: December 21, 2021
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventor: Cynthia C. Bamdad
  • METHOD FOR MAKING PLURIPOTENT STEM CELLS
    Publication number: 20210054358
    Abstract: The present application discloses a method for inducing cells to gain characteristics of naïve stem cell state comprising culturing the cells in the presence of a MUC1* activator.
    Type: Application
    Filed: June 25, 2020
    Publication date: February 25, 2021
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventor: Cynthia Bamdad
  • PROLIFERATION OF MUC1 EXPRESSING CELLS
    Publication number: 20200385485
    Abstract: The present application discloses a method for stimulating or enhancing proliferation of a population of cells by activating MUC1 receptor on the cells.
    Type: Application
    Filed: July 6, 2020
    Publication date: December 10, 2020
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventor: Cynthia Bamdad
  • MUC1* ANTIBODIES
    Publication number: 20200239594
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Application
    Filed: August 13, 2019
    Publication date: July 30, 2020
    Applicant: Minerva Biotechnologies Corporation
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • Method for making pluripotent stem cells
    Patent number: 10724027
    Abstract: The present application discloses a method for inducing cells to gain characteristics of naïve stem cell state comprising culturing the cells in the presence of a MUC1* activator.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: July 28, 2020
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventor: Cynthia Bamdad
  • Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor
    Patent number: 10703821
    Abstract: The present application discloses a method for stimulating or enhancing proliferation of a population of cells by activating MUC1 receptor on the cells.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: July 7, 2020
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia Bamdad
  • METHOD FOR MAKING PLURIPOTENT STEM CELLS
    Publication number: 20200190502
    Abstract: The present application discloses a method for inducing cells to gain characteristics of naïve stem cell state comprising culturing the cells in the presence of a MUC1* activator.
    Type: Application
    Filed: September 17, 2013
    Publication date: June 18, 2020
    Applicant: Minerva Biotechnologies Corporation
    Inventor: Cynthia Bamdad
  • NUCLEIC ACID ENCODING GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS
    Publication number: 20200062812
    Abstract: The present application discloses a recombinantly made protein construct that preferentially forms multimers.
    Type: Application
    Filed: June 20, 2019
    Publication date: February 27, 2020
    Applicant: Minerva Biotechnologies Corporation
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • HUMANIZED ANTI-MUC1* ANTIBODIES AND USE OF CLEAVAGE ENZYME
    Publication number: 20190290692
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof and use of cleavage enzyme.
    Type: Application
    Filed: October 11, 2017
    Publication date: September 26, 2019
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe, Luke Deary